Dr. rer. nat. Thomas Nesselhut, PhD

Dr. rer. nat. Thomas Nesselhut, PhD, with decades of experience, is a renowned specialist in dendritic cells, oncology, and immunotherapy, working at Practice Group for Cell Therapy Duderstadt in Germany. Dr. Nesselhut has an impressive CV, including post-doctoral fellowships and board certification in obstetrics and gynecology. Notably, he established the Laboratory of Tumor Immunology at the University Hospital in Gottingen and pioneered the production of autologous tumor vaccines, expanding to cell-based therapies for degenerative diseases. Dr. Nesselhut's focus on cell-based regenerative therapy and cancer vaccines is evident in his scientific publications. His research on dendritic cell therapy in various cancers, including glioblastoma and breast cancer, showcases his expertise and dedication to innovative treatments. With a track record of successful outcomes and a commitment to advancing personalized medicine, Dr. Nesselhut is recognized for his contributions to the field of oncology and immunotherapy.